106 related articles for article (PubMed ID: 623673)
1. Toxicity of combinations of arabinosylcytosine and 3-deazauridine toward neoplastic cells in culture.
Mills-Yamamoto C; Lauzon GJ; Paterson AR
Biochem Pharmacol; 1978 Jan; 27(2):181-6. PubMed ID: 623673
[No Abstract] [Full Text] [Related]
2. Cell cycle arrest as a basis of enhancement of 1-beta-D-arabinofuranosylcytosine anabolism in human lymphoblastoid RPMI 6410 cells cultured with 3-deazauridine.
Lauzon GJ; Yang S; Paterson AR
Biochem Pharmacol; 1981 Jul; 30(14):1889-94. PubMed ID: 6895033
[No Abstract] [Full Text] [Related]
3. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
[TBL] [Abstract][Full Text] [Related]
4. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
Moriconi WJ; Slavik M; Taylor S
Invest New Drugs; 1986; 4(1):67-84. PubMed ID: 2422137
[TBL] [Abstract][Full Text] [Related]
5. Enzyme pattern-directed chemotherapy: synergistic interaction of 3-deazauridine with D-galactosamine.
Jackson RC; Williams JC; Weber G
Cancer Treat Rep; 1976 Jul; 60(7):835-43. PubMed ID: 188552
[TBL] [Abstract][Full Text] [Related]
6. The effect of 3-deazauridine and dipyridamole on uridine utilization by mice.
Moyer JD; Malinowski N; Cysyk RL
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):323-7. PubMed ID: 2423341
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridine.
Momparler RL; Bouffard DY; Momparler LF; Marquet J; Zittoun J; Marie JP; Zittoun R
Int J Cancer; 1991 Oct; 49(4):573-6. PubMed ID: 1917159
[TBL] [Abstract][Full Text] [Related]
8. The disposition of 3-deazauridine in mice.
Cysyk RL; Gormley PE; D'Anna ME; Adamson RH
Drug Metab Dispos; 1978; 6(2):125-32. PubMed ID: 26526
[No Abstract] [Full Text] [Related]
9. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
10. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
Karle JM; Cysyk RL
Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
[TBL] [Abstract][Full Text] [Related]
11. Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells.
Dahlig-Harley E; Paterson AR; Robins MJ; Cass CE
Cancer Res; 1984 Jan; 44(1):161-5. PubMed ID: 6580947
[TBL] [Abstract][Full Text] [Related]
12. Ara-C metabolism: implications for drug resistance and drug interactions.
Chabner BA; Hande KR; Drake JC
Bull Cancer; 1979; 66(1):89-92. PubMed ID: 420952
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography.
Plunkett W; Chubb S; Barlogie B
J Chromatogr; 1980 Dec; 221(2):425-30. PubMed ID: 6938519
[No Abstract] [Full Text] [Related]
14. In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia.
Barlogie B; Plunkett W; Raber M; Latreille J; Keating M; McCredie K
Cancer Res; 1981 Mar; 41(3):1227-35. PubMed ID: 7459863
[No Abstract] [Full Text] [Related]
15. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.
Lauzon GJ; Paterson AR; Belch AW
Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175
[TBL] [Abstract][Full Text] [Related]
16. Enzyme pattern-directed chemotherapy. Effects of antipyrimidine combinations on the ribonucleotide content of hepatomas.
Lui MS; Jackson RC; Weber G
Biochem Pharmacol; 1979 Apr; 28(7):1189-95. PubMed ID: 444276
[No Abstract] [Full Text] [Related]
17. The regulation of thymidylate biosynthesis in Novikoff hepatoma cells and the effects of amethopterin, 5-fluorodeoxyuridine, and 3-deazauridine.
Jackson RC
J Biol Chem; 1978 Oct; 253(20):7440-6. PubMed ID: 151682
[No Abstract] [Full Text] [Related]
18. Drug sequence-dependent toxicity and small bowel mucosal injury in mice treated with low doses of 3-deazauridine and 1-beta-D-arabinofuranosylcytosine.
Paterson AR; Jakobs ES; Lauzon GJ; Weinstein WM
Cancer Res; 1979 Jun; 39(6 Pt 1):2216-9. PubMed ID: 445420
[TBL] [Abstract][Full Text] [Related]
19. Homogeneous uridine kinase from Ehrlich ascites tumor: substrate specificity and inhibition by bisubstrate analogs.
Cheng N; Payne RC; Kemp WE; Traut TW
Mol Pharmacol; 1986 Aug; 30(2):159-63. PubMed ID: 3016499
[TBL] [Abstract][Full Text] [Related]
20. Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.
Drake JC; Hande KR; Fuller RW; Chabner BA
Biochem Pharmacol; 1980 Mar; 29(5):807-11. PubMed ID: 20227960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
